The chemical class of LANCL1 activators listed here primarily includes compounds that are known to modulate various cellular signaling pathways. These activators are not specific to LANCL1 but could potentially influence its function indirectly. Abscisic Acid, a plant hormone, has been reported to bind LANCL1 and may influence its signaling activity. This interaction suggests a potential role for Abscisic Acid in modulating LANCL1 function. PPAR-γ agonists like Pioglitazone and Rosiglitazone, as well as the endogenous ligand 15-Deoxy-Δ12,14-prostaglandin J2, might influence LANCL1 indirectly through the activation of PPAR-γ signaling pathways, which are involved in various metabolic processes.
Metformin affects metabolic signaling and could have indirect effects on LANCL1 function. AICAR, which activates AMPK, is another compound that could impact pathways related to LANCL1. Berberine and Curcumin are known for their effects on metabolic and signaling pathways and could potentially influence LANCL1. Forskolin, by increasing cAMP levels, might also modulate cellular processes affecting LANCL1. Resveratrol, a compound with various effects on signaling pathways, and Spermidine, involved in autophagy and cellular signaling, could potentially impact LANCL1 activity. Lithium Chloride, which affects various pathways including GSK-3β inhibition, might have an indirect influence on LANCL1 function. It is important to note that these effects on LANCL1 are theoretical, based on the known actions of these compounds in cellular signaling. Direct studies focusing on LANCL1 and these chemicals might be limited. Therefore, experimental validation is essential for confirming any potential interactions or effects on LANCL1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A PPAR-γ agonist, might influence LANCL1 indirectly through peroxisome proliferator-activated receptor-gamma pathways. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Similar to Pioglitazone, as a PPAR-γ agonist, could indirectly affect LANCL1 via PPAR-γ signaling pathways. | ||||||
15-Deoxy-δ12,14-Prostaglandin J2 | 87893-55-8 | sc-201262 sc-201262A | 1 mg 5 mg | $141.00 $551.00 | 5 | |
An endogenous ligand for PPAR-γ, potentially influencing LANCL1 activity through PPAR-γ modulation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMP-activated protein kinase (AMPK), potentially affecting pathways related to LANCL1. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
A compound known to influence metabolic pathways, potentially affecting LANCL1 indirectly. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known to modulate various signaling pathways, it could indirectly affect LANCL1 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and may indirectly influence LANCL1 activity in cells. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Affects various signaling pathways and could indirectly influence LANCL1 activity through these pathways. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Involved in cellular signaling and autophagy, potentially influencing LANCL1 indirectly. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects various signaling pathways, including GSK-3β inhibition, potentially impacting LANCL1 function indirectly. | ||||||